المؤلفون: Pierce BG; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA., Felbinger N; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA., Metcalf M; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA., Toth EA; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA., Ofek G; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA., Fuerst TR; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.

المصدر: Viruses [Viruses] 2024 May 18; Vol. 16 (5). Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

مواضيع طبية MeSH: Hepacivirus*/immunology , Hepacivirus*/genetics , Hepacivirus*/chemistry , Viral Envelope Proteins*/immunology , Viral Envelope Proteins*/chemistry , Viral Envelope Proteins*/genetics , Vaccine Development* , Viral Hepatitis Vaccines*/immunology , Hepatitis C*/prevention & control , Hepatitis C*/immunology , Hepatitis C*/virology, Humans ; Antibodies, Neutralizing/immunology ; Animals ; Hepatitis C Antibodies/immunology

المؤلفون: Abravanel F; Inserm UMR 1291, CNRS UMR5051, Université Toulouse III, 31000 Toulouse, France. Electronic address: abravanel.f@chu-toulouse.fr., Lhomme S; CHU Toulouse, Hôpital Purpan, Laboratoire de Virologie, National Reference Centre for Hepatitis E, Toulouse, France.

المصدر: Lancet (London, England) [Lancet] 2024 Mar 02; Vol. 403 (10429), pp. 782-783. Date of Electronic Publication: 2024 Feb 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Vaccines, Synthetic* , Viral Hepatitis Vaccines*, Humans

المؤلفون: Huang S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Zhang X; Jiangsu Provincial Centre for Disease Control and Prevention, Nanjing, China., Su Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Zhuang C; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Tang Z; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Huang X; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Chen Q; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Zhu K; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Hu X; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Ying D; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Liu X; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Jiang H; Dongtai Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Zang X; Dongtai Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Wang Z; Dongtai Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Yang C; Dongtai Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Liu D; Dongtai Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Wang Y; Dongtai Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Tang Q; Yancheng Centre for Disease Control and Prevention, Yancheng, Jiangsu, China., Shen W; Xiamen Innovax Biotech Company, Xiamen, China., Cao H; Xiamen Innovax Biotech Company, Xiamen, China., Pan H; Xiamen Innovax Biotech Company, Xiamen, China., Ge S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Huang Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Wu T; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Zheng Z; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China., Zhu F; Jiangsu Provincial Centre for Disease Control and Prevention, Nanjing, China., Zhang J; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China. Electronic address: zhangj@xmu.edu.cn., Xia N; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, the Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China. Electronic address: nsxia@xmu.edu.cn.

المصدر: Lancet (London, England) [Lancet] 2024 Mar 02; Vol. 403 (10429), pp. 813-823. Date of Electronic Publication: 2024 Feb 19.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis E*/prevention & control , Viral Hepatitis Vaccines*, Adult ; Humans ; Antibodies, Viral ; Vaccination

المؤلفون: Haga Y; Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA., Meyer K; Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA., Sung MMH; Acuitas Therapeutics, Vancouver, Canada., Reagan EK; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Weissman D; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ray R; Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA.; Department of Molecular Microbiology & Immunology, Saint Louis University, St. Louis, Missouri, USA.

المصدر: Journal of virology [J Virol] 2024 Jan 23; Vol. 98 (1), pp. e0180923. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis C* , Viral Hepatitis Vaccines*, Animals ; Humans ; Mice ; Hepacivirus/genetics ; Hepatitis C Antibodies ; Hepatitis C Antigens ; Leukocytes, Mononuclear ; RNA, Messenger ; Viral Envelope Proteins/metabolism ; Viral Vaccines

المؤلفون: Malaina I; Department of Mathematics, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain. iker.malaina@ehu.eus.; Biocruces Health Research Institute, Bilbao, Spain. iker.malaina@ehu.eus., Martinez L; Department of Mathematics, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain.; Biocruces Health Research Institute, Bilbao, Spain.; Basque Center of Applied Mathematics (BCAM), 48009, Bilbao, Spain., Salcines-Cuevas D; Facultad de Ciencias de La Salud, Universidad Internacional de La Rioja (UNIR), MEDONLINE Group, Avda. de La Paz, 137, 26006, Logroño, La Rioja, Spain., Teran-Navarro H; Facultad de Ciencias de La Salud, Universidad Internacional de La Rioja (UNIR), MEDONLINE Group, Avda. de La Paz, 137, 26006, Logroño, La Rioja, Spain., Ocejo-Vinyals JG; Servicio de Inmunología, Cantabria and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Avda. de Valdecilla S/N, 39008, Santander, Spain., Gonzalez-Lopez E; Servicio de Inmunología, Cantabria and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Avda. de Valdecilla S/N, 39008, Santander, Spain., Soriano V; Facultad de Ciencias de La Salud, Universidad Internacional de La Rioja (UNIR), MEDONLINE Group, Avda. de La Paz, 137, 26006, Logroño, La Rioja, Spain., Ubeda M; Facultad de Ciencias de La Salud, Universidad Internacional de La Rioja (UNIR), MEDONLINE Group, Avda. de La Paz, 137, 26006, Logroño, La Rioja, Spain., Perez Pinilla MB; Department of Mathematics, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain., Martinez de la Fuente I; Centro de Edafología y Biología Aplicada del Segura, 30100, Murcia, Spain., Alvarez-Dominguez C; Facultad de Ciencias de La Salud, Universidad Internacional de La Rioja (UNIR), MEDONLINE Group, Avda. de La Paz, 137, 26006, Logroño, La Rioja, Spain. carmen.alvarez@unir.net.

المصدر: Scientific reports [Sci Rep] 2023 Dec 08; Vol. 13 (1), pp. 21746. Date of Electronic Publication: 2023 Dec 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Viral Hepatitis Vaccines* , Hepatitis C*, Humans ; Hepacivirus ; Epitopes ; Immunity, Cellular

المؤلفون: Lesnova EI; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Masalova OV; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Permyakova KY; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation.; Moscow State Academy of Veterinary Medicine and Biotechnology - MVA by K.I. Skryabin., Demidova NA; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Valuev-Elliston VT; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences., Ivanov AV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences., Kushch AA; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation.

المصدر: Voprosy virusologii [Vopr Virusol] 2023 Sep 21; Vol. 68 (4), pp. 315-326. Date of Electronic Publication: 2023 Sep 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: FBUN T︠S︡NII Ėpidemiologii Rospotrebnadzora Country of Publication: Russia (Federation) NLM ID: 0417337 Publication Model: Electronic Cited Medium: Internet ISSN: 2411-2097 (Electronic) Linking ISSN: 05074088 NLM ISO Abbreviation: Vopr Virusol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis C* , Toll-Like Receptor 4*/agonists , Vaccines, DNA*/pharmacology , Viral Hepatitis Vaccines*/pharmacology, Animals ; Mice ; Adjuvants, Immunologic/pharmacology ; Hepacivirus ; Immunity, Cellular ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Inbred DBA ; Recombinant Proteins ; Viral Nonstructural Proteins

المؤلفون: Toth EA; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, Maryland, USA., Andrianov AK; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, Maryland, USA., Fuerst TR; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, Maryland, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA.

المصدر: Reviews in medical virology [Rev Med Virol] 2023 Sep; Vol. 33 (5), pp. e2474. Date of Electronic Publication: 2023 Aug 11.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1654 (Electronic) Linking ISSN: 10529276 NLM ISO Abbreviation: Rev Med Virol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis C*/prevention & control , Viral Vaccines* , Viral Hepatitis Vaccines*, Humans ; Hepacivirus/genetics ; Antibodies, Neutralizing ; Viral Envelope Proteins/genetics

المؤلفون: Ahmad S; Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, P.O. Box 36, Lebanon; Department of Natural Sciences, Lebanese American University, Beirut, P.O. Box 36, Lebanon., Demneh FM; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran., Rehman B; Institute of Biotechnology and Microbiology, Bacha khan University, Charsadda, Pakistan., Almanaa TN; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia., Akhtar N; School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India., Pazoki-Toroudi H; Department of Physiology & Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran., Shojaeian A; Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran., Ghatrehsamani M; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Electronic address: mahdi.samani.2020@gmail.com., Sanami S; Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran. Electronic address: samirasanami34@yahoo.com.

المصدر: International journal of biological macromolecules [Int J Biol Macromol] 2024 May; Vol. 267 (Pt 2), pp. 131517. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE

مواضيع طبية MeSH: Hepacivirus*/immunology , Epitopes, T-Lymphocyte*/immunology , Epitopes, T-Lymphocyte*/chemistry , Molecular Docking Simulation* , Computational Biology*/methods , Hepatitis C*/prevention & control , Hepatitis C*/immunology , Epitopes, B-Lymphocyte*/immunology , Epitopes, B-Lymphocyte*/chemistry , Molecular Dynamics Simulation*, Humans ; Toll-Like Receptor 4/immunology ; Toll-Like Receptor 4/metabolism ; Toll-Like Receptor 2/immunology ; Toll-Like Receptor 2/chemistry ; Viral Hepatitis Vaccines/immunology ; Viral Hepatitis Vaccines/chemistry ; Computer Simulation ; Viral Envelope Proteins/immunology ; Viral Envelope Proteins/chemistry ; Immunoinformatics

المؤلفون: Gomez-Escobar E; Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France., Roingeard P; Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France., Beaumont E; Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.

المصدر: Viruses [Viruses] 2023 May 11; Vol. 15 (5). Date of Electronic Publication: 2023 May 11.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis C, Chronic*/prevention & control , Hepatitis C* , Viral Hepatitis Vaccines*, Humans ; Antibodies, Neutralizing ; Viral Envelope Proteins/metabolism ; Antiviral Agents/metabolism ; Hepacivirus ; Hepatitis C Antibodies

المؤلفون: Masalova OV; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Lesnova EI; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Andreev SM; NRC Institute of Immunology FMBA of Russia., Shershakova NN; NRC Institute of Immunology FMBA of Russia., Kozlov VV; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Permyakova KY; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation.; Federal State Budgetary Educational Institution of Higher Education «Moscow State Academy of Veterinary Medicine and Biotechnology - MVA by K.I. Skryabin»., Demidova NA; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Valuev-Elliston VT; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences., Turetskiy EA; NRC Institute of Immunology FMBA of Russia.; Sechenov First Moscow State Medical University (Sechenov University)., Ivanov AV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences., Nikolaeva TN; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Khaitov MR; NRC Institute of Immunology FMBA of Russia.; Pirogov Russian National Research Medical University., Pronin AV; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation., Kushch AA; Gamaleya NRC of Epidemiology and Microbiology, Ministry of Health of the Russian Federation.

المصدر: Voprosy virusologii [Vopr Virusol] 2023 Feb 07; Vol. 67 (6), pp. 516-526. Date of Electronic Publication: 2023 Feb 07.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: FBUN T︠S︡NII Ėpidemiologii Rospotrebnadzora Country of Publication: Russia (Federation) NLM ID: 0417337 Publication Model: Electronic Cited Medium: Internet ISSN: 2411-2097 (Electronic) Linking ISSN: 05074088 NLM ISO Abbreviation: Vopr Virusol Subsets: MEDLINE

مواضيع طبية MeSH: Fullerenes*/pharmacology , Fullerenes*/metabolism , Hepatitis C* , Vaccines, DNA*/genetics , Vaccines, DNA*/pharmacology , Viral Hepatitis Vaccines*/genetics , Viral Hepatitis Vaccines*/pharmacology, Mice ; Animals ; Hepacivirus ; Base Sequence ; Amino Acids/genetics ; Amino Acids/metabolism ; Amino Acids/pharmacology ; Mice, Inbred C57BL ; Adjuvants, Immunologic/genetics ; Immunity, Cellular ; Recombinant Proteins/genetics ; Mice, Inbred BALB C